Medline Inc. announces pricing of secondary offering of class A common stock

NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) at a price to the public of $41.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. The offering is expected to close on March 10, 2026, subject to customary closing conditions.

GlobeNewsWire • Mar 5, 2026

Medline Inc. announces launch of secondary offering of Class A common stock

NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) have commenced an underwritten public offering of 75,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock.

GlobeNewsWire • Mar 3, 2026

Medline Analysts Boost Their Forecasts Following Q4 Results

Medline Inc (NASDAQ: MDLN) reported mixed results for the fourth quarter on Wednesday.

Benzinga • Feb 26, 2026

IPO Stock Falls In First Earnings Report Since Huge Initial Offering

Medline reported fourth-quarter sales of $7.8 billion, an increase of 14.8%, beating estimates of $7.115 billion.

Investors Business Daily • Feb 25, 2026

Medline Inc. (MDLN) Q4 2025 Earnings Call Transcript

Medline Inc. (MDLN) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 25, 2026

Medline Reports Fourth Quarter and Full Year 2025 Results

NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care2, today reported its operating results for the three months and full year ended December 31, 2025.

GlobeNewsWire • Feb 25, 2026

Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?

MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.

Zacks Investment Research • Feb 24, 2026

Biggest IPO In Years Is A Winner So Far, But This Key Test Looms

Medline, the nation's largest provider of medical supplies, will release its first post-IPO earnings report on Wednesday.

Investors Business Daily • Feb 19, 2026

Medline announces participation in the Barclays 28th Annual Global Healthcare Conference

NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET.

GlobeNewsWire • Feb 18, 2026

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio

Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? Medline looks primed and ready to continue delivering on its history of rapid, profitable sales growth These 10 Stocks Could Mint the Next Wave of Millionaires ›

The Motley Fool • Feb 5, 2026